Business Context and Reporting Period
This Form 8-K was filed by MRI Interventions, Inc. on November 4, 2016. The filing serves to announce the Company's financial performance for the quarter and nine months ended September 30, 2016. Note: The request metadata lists "Clearpoint Neuro, Inc.", but the filing text explicitly identifies the registrant as "MRI Interventions, Inc."
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references a press release (Exhibit 99.1) and an investor presentation (Exhibit 99.2) containing these details, but the text of the 8-K itself does not disclose the figures.
Material Changes
The filing does not contain specific data regarding material changes versus prior periods. It only confirms the issuance of a press release detailing performance for the period ended September 30, 2016.
Guidance, Outlook, and Risks
- Disclosure: The Company posted an updated investor presentation to its website on November 4, 2016, which may be used in conversations with analysts and investors.
- Forward-Looking Statements: The filing explicitly states that the information in the attached exhibits is not deemed "filed" under the Exchange Act and is not incorporated by reference unless specifically cited.
- Update Obligation: The Company undertakes no duty or obligation to publicly update or revise the information contained in the investor presentation, though it may do so at management's discretion.
Investor Verification Checklist
- Verify the specific financial results (revenue, net loss, cash position) in the Press Release dated November 4, 2016 (Exhibit 99.1), as these are not included in the 8-K text.
- Review the Investor Presentation (Exhibit 99.2) for updated strategic outlook and operational metrics.
- Confirm the registrant name is MRI Interventions, Inc. and not Clearpoint Neuro, Inc., as indicated in the filing header.
- Note that the financial data in the exhibits is not legally "filed" for liability purposes under Section 18 of the Exchange Act unless specifically referenced in other filings.